Business Outline

Basic Information

Company Name Mitsubishi Tanabe Pharma Corporation
Capital Stock 50 billion yen
Representative Director UENO Hiroaki
Headquarters 3-2-10, Dosho-machi, Chuo-ku,
Osaka 541-8505, Japan
TEL: 81-6-6205-5085
Number of Employees 6,697 (Consolidated)  3,268 (Non-consolidated)(As of March 31, 2022)
Incorporated December 13, 1933
Date of Merger October 1, 2007

Business Activities


Manufacture and sale of pharmaceuticals, centered on ethical drugs

Major Ethical Drugs

Central nervous system Lexapro, Uplizna
Immuno-inflammation Stelera, Simponi, Imusera
Vaccines Influenza vaccine, TETRABIK, varicella vaccine, Mearubik, JEBIK V
Others Diabetes and kidney Tenelia, Canaglu, Canalia, Vafseo
Allergy Rupafin

Major OTC Drugs

Agent for treatment of skin conditions Flucort f, Cort f series
Digestive medicine Tanabe ichoyaku〈choritsu〉, Tanabe ichoyaku urso, Cerekinon S
Digestive drink Urso ukon
Nutrient and tonic drink Aspara drink α
Allergic rhinitis medication Talion AR

This website uses cookies to provide better content. By browsing this site, you accept our use of cookies.
Privacy Policy